Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02952261
Other study ID # k16-284
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 24, 2016
Est. completion date October 25, 2017

Study information

Verified date December 2018
Source Shanghai Pulmonary Hospital, Shanghai, China
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial is to evaluate the efficacy and safety of three-dimensional printed navigational template in the clinical application of small peripheral lung nodule localization.


Description:

Localization of small lung nodule is challenging due to the difficulty of nodule recognition during VATS. A three-dimensional printed navigational template was designed to aid percutaneous lung nodule localization, and its feasibility has been confirmed in previous study. The trial was conducted to confirm the non-inferiority of template-guided method to conventional CT-guided method in terms of localization accuracy.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date October 25, 2017
Est. primary completion date October 1, 2017
Accepts healthy volunteers No
Gender All
Age group 19 Years to 80 Years
Eligibility Inclusion Criteria:

1. Aged from 19 to 80 years

2. lesions located in peripheral lung tissue which can be removed by wedge resection

3. The maximum diameter of the lesion is no more than 20 mm.

4. Research assistant consulted with the patient's surgeon to confirm the necessity of lung nodule localization

5. Informed consent was signed voluntarily.

Exclusion Criteria:

1. nodule located in the scapula region.

2. there were two or more lung nodules needed to be localized.

Study Design


Intervention

Device:
template-guided localization
Based on CT data, digital model of the navigational template was created using CAD software and imported to 3D printer. The navigational template serves as a guider to the localizer in lung nodule localization.
Other:
CT-guided localization
Percutaneous lung nodule localization was conducted under the real-time guidance of CT scan. This is the conventional method of transthoracic lung nodule localization.

Locations

Country Name City State
China Shanghai Pulmonary Hospital Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Chang Chen

Country where clinical trial is conducted

China, 

References & Publications (1)

Zhang L, Li M, Li Z, Kedeer X, Wang L, Fan Z, Chen C. Three-dimensional printing of navigational template in localization of pulmonary nodule: A pilot study. J Thorac Cardiovasc Surg. 2017 Dec;154(6):2113-2119.e7. doi: 10.1016/j.jtcvs.2017.08.065. Epub 2017 Sep 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of Lung Nodule Localization Localization accuracy was defined by the localizer deviation between the hookwire and the center of the target nodule. (The deviation was measured using CAD software after downloading the CT images from the Picture Archiving and Communication Systems.) From the time of completing final CT scan, assessed up to 2 days.
Secondary Procedural Duration of the Nodule Localization Procedural duration was derived from CT scan parameters, which was calculated as the time length between the initial and final scan. From the time of completing final CT scan, assessed up to 1 hour.
Secondary Radiation Dose Radiation dosage was read on the monitor screen of CT scanner and converted to effective dosage. From the time of completing final CT scan, assessed up to 1 hour.
Secondary Complication Rate Pnuemothorax related to lung nodule localization From the time of completing final CT scan, assessed up to 2 days.
See also
  Status Clinical Trial Phase
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Completed NCT04508270 - Significance of Early Mobilization After VATS-L
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Completed NCT05469425 - Home-based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery N/A
Recruiting NCT05046067 - Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery N/A
Terminated NCT03090880 - Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) Phase 3
Recruiting NCT05596760 - Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers N/A
Completed NCT02498860 - Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung Phase 2
Not yet recruiting NCT06024538 - Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
Recruiting NCT02965300 - The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis N/A
Completed NCT02616211 - An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Recruiting NCT00765986 - Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy N/A
Completed NCT03320044 - Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
Recruiting NCT03655015 - Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Completed NCT03741868 - Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy
Not yet recruiting NCT05179408 - Telerehabilitation Following Lung Cancer N/A
Completed NCT03749512 - NLCR in Prediction of the Grade of Lung Tumor.
Recruiting NCT03664843 - Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
Completed NCT01261507 - Reader Study of DeltaView™ Chest Radiograph Software N/A
Terminated NCT01064050 - Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers Phase 4